Clinical Trials Directory

Trials / Recruiting

RecruitingNCT00515567

Explanted Lung Tissues With Pulmonary Fibrosis

Utilization of Explanted Lungs for Isolation of Tissue Samples and Primary Cell Lines to Study Pulmonary Fibrosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to use the tissues from the explanted lungs in order to better study the cause of pulmonary fibrosis at a cellular level.

Detailed description

Pulmonary Fibrosis involves scarring of the lung. Gradually, the air sacs of the lungs become replaced by fibrotic tissue. The most current thinking is that the fibrotic process is a reaction to tiny injury to the lung. When the scar forms, the tissue becomes thicker causing a permanent loss of the tissue's ability to carry oxygen into the bloodstream. We need to obtain lung tissue from patients without pulmonary fibrosis and compare it to lung tissue from patients with pulmonary fibrosis.

Conditions

Timeline

Start date
2006-02-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2007-08-13
Last updated
2026-01-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00515567. Inclusion in this directory is not an endorsement.